1. Duncan, R. (2003). The dawning era of polymer therapeutics, Nature reviews, Drug discovery, vol. 2, p. 347.
2.
2. Danusso, F. and Ferruti, P. (1970). Polymer, 11: 88 .
3.
3. Ferruti, P., Marchisio, M. A. and Barbucci, R. (1985). Polymer, 26: 1336 .
4.
4. Ferruti, P. “Ion-Chelating Polymers (Medical Applications)”, in: Polymeric Materials Enciclopedia, vol. 5, J. C. Salamone, Ed. CRC Press INC, Boca Raton, Florida 1996, pp. 3334–3359.
5.
5. Malgesini, B., Verpilio, I., Duncan, R. and Ferruti, P. (2003). Macromol. Biosci., 3: 59–66 .
6.
6. Tanzi, M. C., Barzaghi, B., Anouchinski, R., Bilenkis, S., Penhasi, A. and Cohn, D. (1992). Biomaterials, 13: 425 .
7.
7. Tanzi, M. C., Pieghi, G., Botto, P., Barozzi, C. and Cardillo, P. (1984). Biomaterials, 5: 357 .
8.
8. Bignotti, F., Sozzani, P., Ranucci, E. and Ferruti, P. (1994). Macromolecules, 27: 7171 .
9.
9. Ferruti, P., Manzoni, S., Richardson, S. C. W., Duncan, R., Pattrick, N. G., Mendichi, R. and Casolaro, M. (2000). Macromolecules, 33: 7793 .
10.
10. Ferruti, P., Ranucci, E., Sartore, L., Bigotti, F., Marchisio, M. A., Bianciardi, P. and Veronese, F. M. (1994). Biomaterials, 15: 1235 .
11.
11. Ferruti, P., Ranucci, E., Bigotti, F., Sartore, L., Bianciardi, P. and Marchisio, M. A. (1994). J. Biomater. Sci. Polym. Ed., 6: 833 .
12.
12. Ranucci, E., Spagnoli, G., Ferruti, P., Sgouras, D. and Duncan, R. (1991). J. Biomater. Sci. Polym. Ed., 2: 303 .
13.
13. Mandel, M. (1992). in Encyclopaedia of Polymer Science and Technology, vol. 11, H. F. Mark, N. G. Gaylord, N. M. Bikales, Eds, Interscience, New York pp. 739–829.
14.
14. Ferruti, P., Marchisio, M. A. and Duncan, R. (2002). “ Feature article ”, Macromol. Rapid Commun., 23: 332–335 .
15.
15. Ringsdorf, H. (1981). J. Polym. Sci. Polym. Symp., 51: 135–153 .
16.
16. Richardson, S. C. W. Ph. D. Thesis at Center of Polymer Therapeutics, School of Pharmacy, Faculty of Medicine, University of London (Dec. 1998).
17.
17. Richardson, S., Ferruti, P. and Duncan, R. (1999). J. Drug Targeting, 6: 391 .
18.
18. Duncan, R. (1992). Anti-Cancer Drugs, 3: 175 .
19.
19. WO 9505,200 (1994), insv.: E. Schacht, P. Ferruti, R. Duncan, Chem. Abstr., 1995, 595, 248301a.
20.
20. Ferruti, P., Ranucci, E., Trotta, F., Gianasi, E., Evagorou, E. G., Wasil, M., Wilson, G. and Duncan, R. (1999). Macromol. Chem. Phys., 200: 1644 .
21.
21. Ohya, Y., Masunaga, T., Baba, T. and Ouchi, T. (1996). J. Macromol. Sci. Pure Appl. Chem., A33(8): 1005 .
22.
22. Sohn, Y. S., Baek, H., Cho, Y. H., Lee, Y., Jung, O., Lee, C. O. and Kim, Y. S. (1997). Int. J. Pharm., 153: 79 .
23.
23. Gianasi, E., Wasil, M., Evagorou, E. G., Keddle, A., Wilson, G. and Duncan, R. (1999). Eur. J. Cancer, 35: 994 .
24.
24. Neuse, E. W., Caldwell, G. and Perlwitz, A. G. (1995). J. Inorg. Organomet. Polym., 5: 195 .
25.
25. Pattrick, N. G.Richardson, S. C. W., Casolaro, M., Ferruti, P. and Duncan, R. (2001). J. Controlled Rel., 77(3): 225–232 .
